Toll-Free1-855-736-3003

Customer Login
Customer Login
Nasolabial folds

Intended for injection into the mid to deep dermal layer for temporary treatment of skin wrinkles and folds in nasolabial folds.

 Clinical Indications
Mid-face and /or Nasolabial folds

Intended for injection into the deep dermal layer for the temporary restoration of volume loss in the area of mid-face.
Relative particle size ~ 467 μM
HA conc.(mg/mL) 20
MoD)mol%) 1.3
CrR(%) 0.181
CrD*(%) 0.235
Storage Modulus at 0.02 Hz (G’., Pa) 261
Lidocaine 0.3%
Composition
Relative particle size ~ 467 μM
HA conc.(mg/mL) 20
MoD)mol%) 1.4
CrR(%) 0.228
CrD*(%) 0.319
Storage Modulus at 0.02 Hz (G’., Pa) 346
Lidocaine 0.3%
Lifting Capacity
30G1/2”TW x 1 and 27G 1/2” TW x 1 Enclosed needles 27G 1/2”TW x 2
1 mL Volume per syrine 1 mL

HICETM: The Innovative Cross-Linking Technology of

HIgh Concentration Equalized (HICE™) is a cross-linking technology developed by LG Chem. HICE™ technology enables a higher cross-linking ratio with a lower concentration of cross-linking agent by using high molecular weight, highly concentrated hyaluronic acid during the cross-linking reaction.

Benefits of HICE™ Cross-linking Technology

High Elasticity

  • High Molecular weight Ha(3 Million Da)
  • Maximum cross-linking ratio with minimum modification

Longer Duration

  • High enzymatic stability

Safety

  • High biocompatibility
  • Lower cross-linking agent(BDDE) content
  • < 2ppm of BDDE

Why Choose YVOIRE®?

  • Used in over 45 countries with over 25 million HA injections
  • High elasticity and safety through HICE™ technology
  • From HA raw material to end product by LG Chem
  • High molecular weight (3 Million Da)
  • Used in over 45 countries with over 25 million HA injections
  • Produced by microbial fermentation (not animal sourced)
  • Comfortable and precise injection with the ergonomic ASIST-Y™ syringe
  • Robust clinical testing (1,500+ subjects) to confirm safety and efficacy

Interested in a Demo?